Watch this on demand seminar (an Illumina satellite symposium recorded at ESMO Immuno-Oncology 2018 Congress, 13–16 December, Geneva, Switzerland) to hear from an expert panel about the value of tumor mutational burden (TMB) assessment.
In this seminar you can learn about TruSight™ Oncology 500 (TSO500), a comprehensive next-generation sequencing (NGS) assay with pan-cancer coverage targeting 523 genes to measure both TMB and microsatellite instability (MSI).
For Research Use Only. Not for use in diagnostic procedures.
QB# 7172Find out more